Published in Nature on December 15, 1988
Common themes in microbial pathogenicity. Microbiol Rev (1989) 7.78
FimH adhesin of type 1 pili is assembled into a fibrillar tip structure in the Enterobacteriaceae. Proc Natl Acad Sci U S A (1995) 3.51
Direct evidence that the FimH protein is the mannose-specific adhesin of Escherichia coli type 1 fimbriae. Infect Immun (1990) 2.94
Identification and sequence analysis of lpfABCDE, a putative fimbrial operon of Salmonella typhimurium. J Bacteriol (1995) 2.27
A TRP Channel Senses Lysosome Neutralization by Pathogens to Trigger Their Expulsion. Cell (2015) 2.24
A murine model of urinary tract infection. Nat Protoc (2009) 2.15
Peptide methionine sulfoxide reductase contributes to the maintenance of adhesins in three major pathogens. Proc Natl Acad Sci U S A (1996) 2.05
Interactions of surfactant protein D with bacterial lipopolysaccharides. Surfactant protein D is an Escherichia coli-binding protein in bronchoalveolar lavage. J Clin Invest (1992) 2.04
Integrin-mediated host cell invasion by type 1-piliated uropathogenic Escherichia coli. PLoS Pathog (2007) 2.01
FimH family of type 1 fimbrial adhesins: functional heterogeneity due to minor sequence variations among fimH genes. J Bacteriol (1994) 2.01
Quantitative differences in adhesiveness of type 1 fimbriated Escherichia coli due to structural differences in fimH genes. J Bacteriol (1995) 1.82
Localization of a domain in the FimH adhesin of Escherichia coli type 1 fimbriae capable of receptor recognition and use of a domain-specific antibody to confer protection against experimental urinary tract infection. J Clin Invest (1997) 1.76
Identification and characterization of a Neisseria gonorrhoeae gene encoding a glycolipid-binding adhesin. Proc Natl Acad Sci U S A (1990) 1.59
The mast cell tumor necrosis factor alpha response to FimH-expressing Escherichia coli is mediated by the glycosylphosphatidylinositol-anchored molecule CD48. Proc Natl Acad Sci U S A (1999) 1.52
TLR4-initiated and cAMP-mediated abrogation of bacterial invasion of the bladder. Cell Host Microbe (2007) 1.47
The mechanical properties of E. coli type 1 pili measured by atomic force microscopy techniques. Biophys J (2006) 1.46
Adhesin presentation in bacteria requires molecular chaperones and ushers. Infect Immun (1992) 1.46
Structure-based drug design and optimization of mannoside bacterial FimH antagonists. J Med Chem (2010) 1.40
Cloning and characterization of the S fimbrial adhesin II complex of an Escherichia coli O18:K1 meningitis isolate. Infect Immun (1993) 1.31
Functional heterogeneity of type 1 fimbriae of Escherichia coli. Infect Immun (1992) 1.31
Fimbrial types among respiratory isolates belonging to the family Enterobacteriaceae. J Clin Microbiol (1991) 1.30
Major surface protein 2 of Anaplasma phagocytophilum facilitates adherence to granulocytes. Infect Immun (2003) 1.29
The affinity of the FimH fimbrial adhesin is receptor-driven and quasi-independent of Escherichia coli pathotypes. Mol Microbiol (2006) 1.28
Surface organelles assembled by secretion systems of Gram-negative bacteria: diversity in structure and function. FEMS Microbiol Rev (2012) 1.26
Mast cells in infection and immunity. Infect Immun (1997) 1.23
Mast cell degranulation induced by type 1 fimbriated Escherichia coli in mice. J Clin Invest (1994) 1.19
Type 1 fimbrial shafts of Escherichia coli and Klebsiella pneumoniae influence sugar-binding specificities of their FimH adhesins. Infect Immun (1994) 1.13
Measuring the forces involved in polyvalent adhesion of uropathogenic Escherichia coli to mannose-presenting surfaces. Proc Natl Acad Sci U S A (2000) 1.08
Pathogenesis of acanthamoeba keratitis. Ocul Surf (2010) 1.05
The Escherichia coli G-fimbrial lectin protein participates both in fimbrial biogenesis and in recognition of the receptor N-acetyl-D-glucosamine. J Bacteriol (1995) 1.01
TLR-mediated immune responses in the urinary tract. Curr Opin Microbiol (2008) 1.00
Binding of nonspecific cross-reacting antigen, a granulocyte membrane glycoprotein, to Escherichia coli expressing type 1 fimbriae. Infect Immun (1991) 0.98
Streptococcal M6 protein binds to fucose-containing glycoproteins on cultured human epithelial cells. Infect Immun (1994) 0.95
Receptor binding domain of Escherichia coli F18 fimbrial adhesin FedF can be both efficiently secreted and surface displayed in a functional form in Lactococcus lactis. Appl Environ Microbiol (2004) 0.94
Glycerol-induced unraveling of the tight helical conformation of Escherichia coli type 1 fimbriae. J Bacteriol (1992) 0.92
Uropathogenic E. coli adhesin-induced host cell receptor conformational changes: implications in transmembrane signaling transduction. J Mol Biol (2009) 0.90
Mapping the binding domain of the F18 fimbrial adhesin. Infect Immun (2003) 0.89
Bacteroides loeschei PK1295 cells express two distinct adhesins simultaneously. Infect Immun (1989) 0.84
Taurolidine antiadhesive properties on interaction with E. coli; its transformation in biological environment and interaction with bacteria cell wall. PLoS One (2010) 0.81
Glycans of bovine lactoferrin function as receptors for the type 1 fimbrial lectin of Escherichia coli. Infect Immun (1996) 0.81
Ordered and ushered; the assembly and translocation of the adhesive type I and p pili. Biology (Basel) (2013) 0.80
Tight conformational coupling between the domains of the enterotoxigenic Escherichia coli fimbrial adhesin CfaE regulates binding state transition. J Biol Chem (2013) 0.79
Conformational inactivation induces immunogenicity of the receptor-binding pocket of a bacterial adhesin. Proc Natl Acad Sci U S A (2013) 0.78
In silico analysis of usher encoding genes in Klebsiella pneumoniae and characterization of their role in adhesion and colonization. PLoS One (2015) 0.76
Immunity to uropathogens: the emerging roles of inflammasomes. Nat Rev Urol (2017) 0.75
Why Serological Responses during Cystitis are Limited. Pathogens (2016) 0.75
Structure, Function, and Assembly of Adhesive Organelles by Uropathogenic Bacteria. Microbiol Spectr (2015) 0.75
Nitazoxanide Inhibits Pilus Biogenesis by Interfering with Folding of the Usher Protein in the Outer Membrane. Antimicrob Agents Chemother (2016) 0.75
Exploitation of SPR to Investigate the Importance of Glycan Chains in the Interaction between Lactoferrin and Bacteria. Sensors (Basel) (2017) 0.75
p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature (1999) 14.38
Bacterial adherence: adhesin-receptor interactions mediating the attachment of bacteria to mucosal surface. J Infect Dis (1981) 14.19
Adherence of coagulase-negative staphylococci to plastic tissue culture plates: a quantitative model for the adherence of staphylococci to medical devices. J Clin Microbiol (1985) 10.22
Adherence of slime-producing strains of Staphylococcus epidermidis to smooth surfaces. Infect Immun (1982) 9.97
Mannose binding and epithelial cell adherence of Escherichia coli. Infect Immun (1978) 5.99
Epithelial cell binding of group A streptococci by lipoteichoic acid on fimbriae denuded of M protein. J Exp Med (1976) 5.55
Cell membrane-binding properties of group A streptococcal lipoteichoic acid. J Exp Med (1975) 5.30
Characterization of clinically significant strains of coagulase-negative staphylococci. J Clin Microbiol (1983) 4.40
Resistance of Neisseria gonorrhoeae to phagocytosis: relationship to colonial morphology and surface pili. J Infect Dis (1974) 4.15
Purification and properties of M protein extracted from group A streptococci with pepsin: covalent structure of the amino terminal region of type 24 M antigen. J Exp Med (1977) 3.62
Primary structure of protective antigens of type 24 streptococcal M protein. J Biol Chem (1980) 3.39
Type-specific protective immunity evoked by synthetic peptide of Streptococcus pyogenes M protein. Nature (1981) 3.38
Requirement for math5 in the development of retinal ganglion cells. Genes Dev (2001) 3.26
Adherence of group A streptococci to fibronectin on oral epithelial cells. Infect Immun (1983) 3.11
The genetic determinant of adhesive function in type 1 fimbriae of Escherichia coli is distinct from the gene encoding the fimbrial subunit. J Bacteriol (1986) 2.93
Repeating covalent structure of streptococcal M protein. Proc Natl Acad Sci U S A (1978) 2.89
Inhibition of human immunodeficiency virus replication by antisense oligodeoxynucleotides. Proc Natl Acad Sci U S A (1988) 2.85
Experimental foreign body infections in mice challenged with slime-producing Staphylococcus epidermidis. Infect Immun (1983) 2.85
Protective antigenic determinant of streptococcal M protein shared with sarcolemmal membrane protein of human heart. J Exp Med (1982) 2.84
Rapid movement of axonal neurofilaments interrupted by prolonged pauses. Nat Cell Biol (2000) 2.75
Role in cell permeability of an essential two-component system in Staphylococcus aureus. J Bacteriol (1999) 2.73
Multiple, heart-cross-reactive epitopes of streptococcal M proteins. J Exp Med (1985) 2.61
Toxic effects of streptococcal M protein on platelets and polymorphonuclear leukocytes in human blood. J Exp Med (1971) 2.59
Epitopes of streptococcal M proteins shared with cardiac myosin. J Exp Med (1985) 2.53
Adherence of streptococcus pyogenes, Escherichia coli, and Pseudomonas aeruginosa to fibronectin-coated and uncoated epithelial cells. Infect Immun (1983) 2.48
Fluorescence, reflectance, and light-scattering spectroscopy for evaluating dysplasia in patients with Barrett's esophagus. Gastroenterology (2001) 2.46
Excretion of lipoteichoic acid by group A streptococci. Influence of penicillin on excretion and loss of ability to adhere to human oral mucosal cells. J Clin Invest (1978) 2.40
Binding of group A streptococci to human oral mucosal cells by lipoteichoic acid. Trans Assoc Am Physicians (1975) 2.32
Identification of Bacillus subtilis genes for septum placement and shape determination. J Bacteriol (1992) 2.31
Identification of two ancillary subunits of Escherichia coli type 1 fimbriae by using antibodies against synthetic oligopeptides of fim gene products. J Bacteriol (1987) 2.26
Delayed hypersensitivity to purified streptococcal m protein in guinea pigs and in man. J Immunol (1969) 2.25
Formation of molecular complexes between a structurally defined M protein and acylated or deacylated lipoteichoic acid of Streptococcus pyogenes. J Bacteriol (1982) 2.22
Roles of a membrane-localized beta subunit in the formation and targeting of functional L-type Ca2+ channels. J Biol Chem (1995) 2.19
Antiopsonic activity of fibrinogen bound to M protein on the surface of group A streptococci. J Clin Invest (1982) 2.19
Peptic digestion of streptococcal M protein. II. Extraction of M antigen from group A streptococci with pepsin. Infect Immun (1974) 2.18
Adherence pharyngeal and skin strains of group A streptococci to human skin and oral epithelial cells. Infect Immun (1977) 2.17
Cloning, sequencing, and expression of a fibronectin/fibrinogen-binding protein from group A streptococci. Infect Immun (1994) 2.15
Inhibition of human immunodeficiency virus in early infected and chronically infected cells by antisense oligodeoxynucleotides and their phosphorothioate analogues. Proc Natl Acad Sci U S A (1989) 2.14
Type-specific inhibition of preopsonization versus immunoprecipitation by Streptococcal M proteins. Infect Immun (1973) 2.13
Photoreceptor cell rescue in retinal degeneration (rd) mice by in vivo gene therapy. Nat Med (1996) 2.12
Interference with the mannose binding and epithelial cell adherence of Escherichia coli by sublethal concentrations of streptomycin. J Clin Invest (1979) 2.10
MRP4: A previously unidentified factor in resistance to nucleoside-based antiviral drugs. Nat Med (1999) 2.07
Hyaluronate capsule prevents attachment of group A streptococci to mouse peritoneal macrophages. Infect Immun (1981) 2.03
Heterogeneity of type-specific and cross-reactive antigenic determinants within a single M protein of group A streptococci. J Exp Med (1980) 2.00
Induction of delayed hypersensitivity to influenza and mumps viruses in mice. J Immunol (1969) 1.99
Fibronectin-mediated binding of group A streptococci to human polymorphonuclear leukocytes. Infect Immun (1982) 1.99
Inhibition of HTLV-III/LAV replication by foscarnet. Biochem Pharmacol (1985) 1.97
Hydroxyurea as an inhibitor of human immunodeficiency virus-type 1 replication. Science (1994) 1.96
Antiadhesive properties of a quaternary structure-specific hybridoma antibody against type 1 fimbriae of Escherichia coli. J Exp Med (1983) 1.96
The regulation of transcription of the gerA spore germination operon of Bacillus subtilis. Mol Microbiol (1990) 1.95
Ki-67, cyclin E, and p16INK4 are complimentary surrogate biomarkers for human papilloma virus-related cervical neoplasia. Am J Surg Pathol (2001) 1.89
Molecular evolution of streptococcal M protein: cloning and nucleotide sequence of the type 24 M protein gene and relation to other genes of Streptococcus pyogenes. J Bacteriol (1988) 1.86
Microtubule actin cross-linking factor (MACF): a hybrid of dystonin and dystrophin that can interact with the actin and microtubule cytoskeletons. J Cell Biol (1999) 1.83
Type-specific immunogenicity of a chemically synthesized peptide fragment of type 5 streptococcal M protein. J Exp Med (1983) 1.82
Bacterial adherence. Adv Intern Med (1980) 1.80
Crystal structure of rat biliverdin reductase. Nat Struct Biol (2001) 1.77
Biochemical and biological properties of the binding of human fibrinogen to M protein in group A streptococci. J Bacteriol (1985) 1.77
Binding of streptococcal lipoteichoic acid to the fatty acid binding sites on serum albumin. J Biol Chem (1980) 1.75
Mediation of cytotoxic effects of streptococcal M protein by nontype-specific antibody in human sera. J Clin Invest (1973) 1.74
Peptic digestion of streptococcal M protein. I. Effect of digestion at suboptimal pH upon the biological and immunochemical properties of purified M protein extracts. Infect Immun (1974) 1.74
Studies of antibodies to non-type-specific antigens associated with streptococcal M protein in the sera of patients with rheumatic fever. J Immunol (1973) 1.73
Inhibition of replication of the etiologic agent of acquired immune deficiency syndrome (human T-lymphotropic retrovirus/lymphadenopathy-associated virus) by avarol and avarone. J Natl Cancer Inst (1987) 1.73
Primary structural similarities between types 5 and 24 M proteins of Streptococcus pyogenes. Biochem Biophys Res Commun (1980) 1.72
Immunochemical properties of streptococcal M protein purified by isoelectric focusing. J Immunol (1975) 1.72
Protection against Escherichia coli-induced urinary tract infections with hybridoma antibodies directed against type 1 fimbriae or complementary D-mannose receptors. Infect Immun (1985) 1.71
Localization of protective epitopes of the amino terminus of type 5 streptococcal M protein. J Exp Med (1986) 1.71
Superantigenicity of streptococcal M protein. J Exp Med (1990) 1.70
Interaction between DNA and alpha/beta-type small, acid-soluble spore proteins: a new class of DNA-binding protein. J Bacteriol (1992) 1.70
Stratified mucin-producing intraepithelial lesions of the cervix: adenosquamous or columnar cell neoplasia? Am J Surg Pathol (2000) 1.70
Streptococcal C5a peptidase is a highly specific endopeptidase. Infect Immun (1992) 1.68
Epitope-specific protective immunogenicity of chemically synthesized 13-, 18-, and 23-residue peptide fragments of streptococcal M protein. Proc Natl Acad Sci U S A (1984) 1.67
Traumatic brain injury induced cell proliferation in the adult mammalian central nervous system. J Neurotrauma (2002) 1.67
Hydrophobic interactions of group A streptococci with hexadecane droplets. J Bacteriol (1983) 1.67
Mutant p53 cooperates with ETS and selectively up-regulates human MDR1 not MRP1. J Biol Chem (2001) 1.67
Eutrophication of lake waters in China: cost, causes, and control. Environ Manage (2010) 1.67
Suppression of bacterial adherence by subminimal inhibitory concentrations of beta-lactam and aminoglycoside antibiotics. Rev Infect Dis (1980) 1.67
Interaction of lipoteichoic acid of group A streptococci with human platelets. Infect Immun (1977) 1.65
Erythrocyte binding properties of streptococcal lipoteichoic acids. Infect Immun (1979) 1.65
Inhibition of complement-mediated opsonization and phagocytosis of Streptococcus pyogenes by D fragments of fibrinogen and fibrin bound to cell surface M protein. J Exp Med (1985) 1.65
Adenovirus vector-mediated in vivo gene transfer into adult murine retina. Invest Ophthalmol Vis Sci (1994) 1.63
G-quadruplexes as targets for drug design. Pharmacol Ther (2000) 1.63
Protective immunity evoked by oral administration of attenuated aroA Salmonella typhimurium expressing cloned streptococcal M protein. J Exp Med (1988) 1.63
Binding of streptococcal lipoteichoic acid to fatty acid-binding sites on human plasma fibronectin. J Bacteriol (1983) 1.63
Effects of cationic porphyrins as G-quadruplex interactive agents in human tumor cells. Cancer Res (1999) 1.63
Enzyme-linked immunosorbent assay for adherence of bacteria to animal cells. J Clin Microbiol (1986) 1.62
Role of shear stress and endothelial prostaglandins in flow- and viscosity-induced dilation of arterioles in vitro. Circ Res (1993) 1.61
Serum opacity factor is a major fibronectin-binding protein and a virulence determinant of M type 2 Streptococcus pyogenes. Mol Microbiol (1999) 1.61
Common protective antigens of group A streptococcal M proteins masked by fibrinogen. J Exp Med (1984) 1.59